Fresenius Medical Care AG & Co. KGaA (FMS), Friday posted third quarter net income attributable to FMC AG & Co. KGaA of $225 million or $0.76 per share, up 9% from $206.34 million or $0.69 per share in the prior year period.
On average, five analysts polled by Thomson Reuters expected the company to earn $0.76 per share. Analysts' estimates typically exclude special items.
Net revenue for the third quarter increased 6.5% to $2.89 billion from $2.71 billion in the previous year period. Street analysts expected revenues of $2.93 billion.
For the nine-month period, net income attributable to FMC AG & Co. KGaA rose to $645 million or $2.16 per share from $603.3 million or $2.03 per share last year. Net revenue for nine months was $8,212 million, up 4% from the same period last year.
Looking forward, for the full year 2009, the company now expects net income attributable to FMC AG & Co. KGaA in the range of $865 million to $890 million. Previously the company expected the net income to be in the range of $850 million and $890 million for the full year 2009.
Revenue is now anticipated to be around $11.2 billion from the prior estimate of $11.1 billion. Street analysts expect earnings of $2.94 per share on revenues of $11.13 billion for the year.
In addition, the company said it expects to spend $550 to $650 million on capital expenditures and $200 to $250 million on acquisitions.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.